Cargando…

Progressive Impairment of Lactate-based Gluconeogenesis in the Huntington’s Disease Mouse Model R6/2

Huntington’s disease (HD) is a neurodegenerative illness, where selective neuronal loss in the brain caused by expression of mutant huntingtin protein leads to motor dysfunction and cognitive decline in addition to peripheral metabolic changes. In this study we confirm our previous observation of im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielsen, Signe Marie Borch, Hasholt, Lis, Nørremølle, Anne, Josefsen, Knud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447482/ https://www.ncbi.nlm.nih.gov/pubmed/26064782 http://dx.doi.org/10.1371/currents.hd.019b33aae1c519e6e8b68e7cf3e7818e

Ejemplares similares

Dysfunctional mitochondrial respiration in the striatum of the Huntington’s disease transgenic R6/2 mouse model
por: Aidt, Frederik Heurlin, et al.
Publicado: (2013)

Effect of Dietary Gluten on Dendritic Cells and Innate Immune Subsets in BALB/c and NOD Mice
por: Larsen, Jesper, et al.
Publicado: (2015)

A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington’s disease
por: Vinther-Jensen, Tua, et al.
Publicado: (2014)

Thalamocortical Projections Are Significantly Impaired in the R6/2 Mouse Model of Huntington’s Disease
por: Holley, S. M., et al.
Publicado: (2022)

Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease
por: Kohl, Zacharias, et al.
Publicado: (2010)

Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
por: Villegas, Luisana, et al.
Publicado: (2021)

Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease
por: Di Pardo, Alba, et al.
Publicado: (2017)

Impaired Nitric Oxide Mediated Vasodilation In The Peripheral Circulation In The R6/2 Mouse Model Of Huntington’s Disease
por: Kane, Andrew D., et al.
Publicado: (2016)

Paroxysmal Cranial Dyskinesia and Nail‐Patella Syndrome Caused by a Novel Variant in the LMX1B Gene
por: Bech, Sara, et al.
Publicado: (2020)

Striatal Pre-Enkephalin Overexpression Improves Huntington’s Disease Symptoms in the R6/2 Mouse Model of Huntington’s Disease
por: Bissonnette, Stéphanie, et al.
Publicado: (2013)

Butyrate stimulates hepatic gluconeogenesis in mouse primary hepatocytes
por: Ji, Xueying, et al.
Publicado: (2019)

Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2019)

Quantification of Huntington’s Disease Related Markers in the R6/2 Mouse Model
por: Etxeberria-Rekalde, Estibaliz, et al.
Publicado: (2021)

Multiplatform metabolomic analysis of the R6/2 mouse model of Huntington’s disease
por: Hashimoto, Masayo, et al.
Publicado: (2021)

Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
por: Stan, Tiberiu Loredan, et al.
Publicado: (2020)

IKKβ slows Huntington’s disease progression in R6/1 mice
por: Ochaba, Joseph, et al.
Publicado: (2019)

The Huntington's Disease-Related Cardiomyopathy Prevents a Hypertrophic Response in the R6/2 Mouse Model
por: Mielcarek, Michal, et al.
Publicado: (2014)

Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington’s disease
por: Sjögren, Marie, et al.
Publicado: (2017)

Regulation of Hepatic Gluconeogenesis by Nuclear Receptor Coactivator 6
por: Oh, Gyun-Sik, et al.
Publicado: (2022)

Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease
por: Bobrowska, Anna, et al.
Publicado: (2011)

PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
por: Cardinale, Antonella, et al.
Publicado: (2015)

White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington’s Disease
por: McCourt, Andrew C., et al.
Publicado: (2016)

Cerebral Gluconeogenesis and Diseases
por: Yip, James, et al.
Publicado: (2017)

Lactate promotes PGE2 synthesis and gluconeogenesis in monocytes to benefit the growth of inflammation-associated colorectal tumor
por: Wei, Libin, et al.
Publicado: (2015)

Glycerol not lactate is the major net carbon source for gluconeogenesis in mice during both short and prolonged fasting
por: Wang, Yujue, et al.
Publicado: (2019)

Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington’s disease by etanercept treatment
por: Pido-Lopez, Jeffrey, et al.
Publicado: (2019)

The PDE1/5 Inhibitor SCH-51866 Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington’s Disease
por: Beaumont, Vahri, et al.
Publicado: (2014)

FoxO6 Integrates Insulin Signaling With Gluconeogenesis in the Liver
por: Kim, Dae Hyun, et al.
Publicado: (2011)

Dysfunctional Behavioral Modulation of Corticostriatal Communication in the R6/2 Mouse Model of Huntington’s Disease
por: Hong, S. Lee, et al.
Publicado: (2012)

Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease
por: Zhu, S, et al.
Publicado: (2011)

Characterization of Striatal Neuronal Loss and Atrophy in the R6/2 Mouse Model of Huntington’s Disease
por: Dodds, Lindsay, et al.
Publicado: (2014)

CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease
por: Comella Bolla, Andrea, et al.
Publicado: (2019)

Glycerol induces G6pc in primary mouse hepatocytes and is the preferred substrate for gluconeogenesis both in vitro and in vivo
por: Kalemba, Katarzyna M., et al.
Publicado: (2019)

Endogenous Nutritive Support after Traumatic Brain Injury: Peripheral Lactate Production for Glucose Supply via Gluconeogenesis
por: Glenn, Thomas C., et al.
Publicado: (2015)

Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington’s Disease
por: Nguyen, Khanh Q., et al.
Publicado: (2016)

Beneficial effects of environmental enrichment and food entrainment in the R6/2 mouse model of Huntington's disease
por: Skillings, Elizabeth A, et al.
Publicado: (2014)

Pyroptotic cell death in the R6/2 mouse model of Huntington’s disease: new insight on the inflammasome
por: Paldino, Emanuela, et al.
Publicado: (2020)

The Urine Metabolome of R6/2 and zQ175DN Huntington’s Disease Mouse Models
por: Speziale, Roberto, et al.
Publicado: (2023)

Unraveling the Regulation of Hepatic Gluconeogenesis
por: Zhang, Xueping, et al.
Publicado: (2019)

Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease
por: Bondulich, Marie Katrin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qfmg46948q91o82qp2flgrhc08